Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Sleep Quality in Older Orthopedic Surgery Patients
NCT05246007Withdrawn
- Sponsor
- Peking University First Hospital
- Start
- May 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in sleep disorders comparing Dexmedetomidine group with Placebo group (2 arms). Primary endpoint: Subjective sleep quality (overall Richards-Campbell Sleep Questionnaire score). Planned start May 2022; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
sleep disorders
Beyond the preview
Go deeper on NCT05246007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05246007.